Iowan Participating In Pfizer COVID-19 Vaccine Trial Reflects On Ongoing Experience
Cedar Rapids City Council Member Ashley Vanorny talks with IPR's Clay Masters about her experience with the Pfizer COVID-19 vaccine testing trial through the University of Iowa.
Pfizer's experimental COVID-19 vaccine appears to be working. On Monday it was reported that the vaccine was found to be more than 90 percent effective, according to clinical results released by the company.
More than 40,000 people are taking part in the clinical study and one of those participants is Ashley Vanorny who works in healthcare administration industry and serves on the Cedar Rapids City Council. She's among 270 people taking part in the University of Iowa's portion of the study. University of Iowa experts say it could still be awhile before the vaccine is widely distributed.
.@uiowa alumna Ashley Vanorny is participating in our #COVID19 vaccine trial. She says, “Being a part of a study that will prevent so many lives from being affected by COVID-19 means the world. I am healthy enough to qualify for this, so I was happy to help.” #UIowaResearch pic.twitter.com/mrWEbX9P8M— University of Iowa Health Care 😷 (@uihealthcare) October 22, 2020